VINCI Construction’s companies play their part in efforts to contain the Covid-19 pandemic, strictly applying public authorities’ recommendations. Protecting everyone’s health and safety are our absolute priorities.

Read the full message
Toggle menu

All expertises

Proton therapy: IBA and VINCI Construction sign a global construction collaboration

10 October, 2017

IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, and VINCI Construction, a global player in building construction, today announce the signing of a memorandum of understanding (MoU), effective immediately, to collaborate in offering dedicated design and construction support to selected proton therapy customers.

Under the terms of the collaboration, IBA will retain leadership of the design of the proton/carbon therapy equipment and VINCI Construction will lead in the design of the building and related technical elements. In addition, VINCI Construction will support IBA in the construction process, ensuring projects are delivered in line with all IBA quality standards, project specifications and timelines.  In due course, IBA and VINCI Construction plan to develop an optimized joint offer to customers. The financial terms of the collaboration are not disclosed.

Olivier Legrain, Chief Executive Officer of IBA, commented: “We are pleased to be collaborating with VINCI Construction and are confident that the combination of our respective expertise will enhance the whole project management process for our customers. The specialist team’s understanding of proton therapy project construction requirements, combined with its global reach, makes it a strong addition to IBA’s leading proton therapy offering.”

Jérôme Stubler, Chairman of VINCI Construction, commented: “Following on from our current collaboration on the Archade proton therapy project in Caen (France), this partnership now enables joint developments on an international scale and strengthens the co-operation between our teams in order to combine complementary expertise, bringing innovative solutions to the leading medical players in the treatment of cancer.”

This website uses cookies. By continuing to browse this site, we will assume that you consent to the use of cookies. Find out more about cookies